I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 9 studies | 27% ± 9% | |
| non-classical monocyte | 8 studies | 29% ± 13% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 3% | |
| classical monocyte | 5 studies | 26% ± 8% | |
| natural killer cell | 5 studies | 19% ± 2% | |
| conventional dendritic cell | 4 studies | 26% ± 8% | |
| epithelial cell | 4 studies | 30% ± 9% | |
| endothelial cell | 4 studies | 23% ± 4% | |
| macrophage | 4 studies | 25% ± 6% | |
| hematopoietic precursor cell | 3 studies | 22% ± 4% | |
| ciliated cell | 3 studies | 27% ± 3% | |
| dendritic cell | 3 studies | 34% ± 11% | |
| goblet cell | 3 studies | 16% ± 1% |
